Trial Profile
Randomized Placebo-Controlled Trial of Ramelteon in the Treatment of Sleep and Mood in Patients With Seasonal Affective Disorder.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Jun 2015
Price :
$35
*
At a glance
- Drugs Ramelteon (Primary)
- Indications Sleep disorders
- Focus Therapeutic Use
- Acronyms SAM-SAD
- 29 Jan 2009 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
- 29 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Nov 2007 Status change from recruiting to in progress.